US crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for stocks under $2. For more, check out Benzinga's insider transactions platform.
Creatd
- The Trade: Creatd, Inc. CRTD Executive Chairman Jeremy Frommer acquired a total of 1,278 shares at an average price of $1.12. To acquire these shares, it cost $1.43 thousand.
- What’s Happening: Creatd recently announced the launch of a new partnership between Dune Glow Remedy, the company's wellness beverage brand, and Urban Outfitters.
- What Creatd Does: Creatd Inc empowers creators, brands, and entrepreneurs through technology and partnership. The company has three platforms, namely Creatd Labs, Creatd Ventures, and Creatd Partners.
Pacific Health Care Organization
- The Trade: Pacific Health Care Organization, Inc. PFHO CEO and President Tom Kubota acquired a total of 1,618 shares at an average price of $0.93. The insider spent around $1.5 thousand to buy those shares.
- What’s Happening: The company recently reported total revenue of $5,403,110 for the year ended December 31, 2021.
- What Pacific Health Care Organization Does: Pacific Health Care Organization Inc is a specialty workers' compensation managed care company. The company serves any size employer in the state of California as well as insurers, third-party administrators, self-administered employers, municipalities and other industries.
Also check this: Insiders Buy More Than $210M Of 3 Stocks
Don’t forget to check out our premarket coverage here .
NaturalShrimp
- The Trade: NaturalShrimp Incorporated SHMP CEO, President Gerald Easterling acquired a total of 150,000 shares at an average price of $0.20. To acquire these shares, it cost around $30.58 thousand.
- What’s Happening: The company’s stock has dropped around 50% since the start of the year.
- What NaturalShrimp Does: NaturalShrimp Inc is a shrimp farming biotechnology company. The firm with its subsidiaries develops proprietary technologies for the growth and sale of natural shrimp indoors without the use of antibiotics or toxic materials.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.